Genmab | GEN - Ebitda





Ebitda Cambiamento Data
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Demant DKK 2.76B 165M 2025-12
Exelixis USD 248.93M 28.02M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GN Store Nord DKK 627M 106M 2025-12
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -314.19M 31.48M 2025-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
UCB EUR 1.6B 570M 2025-12